OncoTherics wins Innovate UK Global Feasibility Study Award

OncoTherics wins Innovate UK Global Feasibility Study Award. Project Title: Exploiting Tumour Hypoxia in Precision Medicine:  Advancing Novel Prodrug Therapies for Pancreatic Cancer with PMCC, a World-leading Canadian Cancer Centre.  As part of the award, OncoTherics will work with Alan Boyd Consultancy to explore a regulatory strategy for its novel hypoxia activated pro-drugs.